Bryan Kim is the founder of Verismo Therapeutics. Verismo Therapeutics has raised $50M in total funding. Backed by HLB Innovation, DongKoo Bio, HLB.
Bryan Kim is the CEO of Verismo Therapeutics, a clinical-stage CAR T cell therapy company. The company, a spinout from the University of Pennsylvania, focuses on pioneering a novel multi-chain KIR-CAR platform technology to treat various cancers. Verismo Therapeutics has raised a total of $50 million since its inception in 2020.
Full founder directory · Investor directory · Company funding database · Fundraising library